AbbVie Inc (ABBV) stock forecast — our track record

Lyra published 9 ABBV stock forecasts starting on September 11, 2025. Every prediction used the short term horizon (0 to 3 months). Each forecast was published before its outcome was known, then closed and scored after its evaluation window ended. The final window ended on July 28, 2026, so all 9 calls had complete outcomes rather than open results.

Two forecasts reached their targets. Seven received partial credit, and none of them missed completely. The average success score was 61.1%. Because every call covered the same short term horizon, there was no medium term or long term record to compare with it. The results therefore showed a clear split: 2 calls fully reached their targets, while the other 7 made some progress but stopped short.

The best call was published on April 29, 2026. It predicted 13% growth, and the stock rose as much as 32.9%. The target was reached after 37 days, and the call received a 100% success score. The worst call was published on November 13, 2025. It predicted 10% growth, while the stock rose as much as 1%. It did not reach the target and received a 50% success score. Overall, the track record was mixed: some calls reached their targets, but most received only partial credit.